Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 4 results for "addp"

Sehwag in NADA's Appeals Panel, dope tainted Kunjarani in ADDP
Rediff.com

Sehwag in NADA's Appeals Panel, dope tainted Kunjarani in ADDP

Legendary opener Virender Sehwag and former Delhi player Vinay Lamba have been made members of the Anti-Doping Appeal Panel (ADAP) of the NADA in a rare instance of cricketers being roped in for such committees. Sehwag and Lamba, who played 76 first-class matches for Delhi between 1967 and 1981, are in the six-member panel headed by retired judge R V Easwar. The other members are senior advocate Vibha Datta Makhija, Dr Naveen Dang and Harsh Mahajan. The panel had a two-hour long meeting today ... Rediff.com, 1 month ago

1 images for "addp"

Rediff.com, 1 month ago
Rediff.com

Sports Shorts: Wrestler Sandeep Yadav banned for four years for failing dope test

Tainted wrestler Narsingh Yadav's former roommate Sandeep Tulsi Yadav, who had also failed the dope test last year, has been handed a four-year ban by the Anti-Doping Disciplinary Panel of the NADA. "Yes, Sandeep has been banned for four years by the NADA ADDP for failing the dope test last year," a top Wrestling Federation of India (WFI) official told PTI. Days after Narsingh had failed his dope test last year ahead of the Rio Olympics, his sparring partner and roommate Sandeep also failed ...
 Rediff.com3 weeks ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less